The mission of new startup Colossal, which has raised $15 million to date, is to genetically reengineer a cold-resistant elephant with all the core biological traits of the extinct woolly mammoth.
https://www.pharmalive.com/wp-content/uploads/2021/10/Colossal-Wants-to-Bring-Back-the-Woolly-Mammoth.-Should-It-BioSpace-10-6-21.jpeg350625Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2021-10-06 02:26:022021-10-06 02:26:40Colossal Wants to Bring Back the Woolly Mammoth